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We previously reported that cryopreservation of tracheas for 1 month was 
possible in a canine tracheal autotransplantation model with use of a preser- 
vative solution containing trehalose. Realizing that the allogenicity of many 
organs is decreased by freezing, we examined the possibility of immunosup- 
pressant-free canine tracheal allotransplantation after long-term cryopreser- 
vation. Six to 10 rings of the trachea were removed from donor dogs (n = 12), 
immersed in the preservative solution, and cryopreserved in a deep freezer at 
-85°C  for 285 -- 28 days (cryopreservation group). Five rings of the 
mediastinal trachea of recipient dogs were removed. The cryopreserved tra- 
cheas were thawed and transplanted to replace the excised mediastinal 
tracheas. In a control group (n = 6), the graft was preserved in Euro-Collins 
solution at 10 ° C for 16 to 17 hours. Allotransplantation of tracheas was done 
as in the cryopreservation group. The anastomotic site and graft were covered 
with an omental pedicle in both groups. In the cryopreservation group, every 
animal, except one that was killed for pathologic examination, survived more 
than 2 months. All the grafts of this group were viable, and no stenosis or 
tracheomalacia was observed. In the control group, most of the animals died 
within 1 month of tracheal stenosis caused by rejection. These findings reveal 
that immunosuppressant-free canine tracheal allotransplantation was consis- 
tently possible after long-term cryopreservation of the graft in a preservative 
solution containing trehalose. This simple method could solve both donor 
shortage and immunosuppression problems. (J Thorac Cardiovasc Surg 1996; 
111:930-4) 
W e have reported that high-dose irradiation pre- vents rejection of canine tracheal allografts 1 
and that reliable 1-month cryopreservation f the 
trachea is possible in a trehalose cryopreservation 
(TC) solution. 2 To solve two major problems of 
tracheal transplantation (rejection and preserva- 
tion) simultaneously, we tried immunosuppressant- 
free tracheal allotransplantation after 1 month of 
cryopreservation in a preliminary experiment. How- 
ever, most grafts were not viable, presumably be- 
cause of severe damage derived from the combina- 
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tion of irradiation and freezing (unpublished ata), 
so we abandoned this approach. 
With regard to cryopreservation itself, there have 
been many reports that the allogenicity of preserved 
allografts is decreased after cryopreservation. 3-6 
Furthermore, we have already reported that cryo- 
preservation can preserve the viability of tracheal 
autografts (especially tracheal cartilage). 2 There- 
fore, we tried immunosuppressant-free tracheal al- 
lotransplantation after long-term cryopreservation 
in TC solution. 
Material and methods 
Animals and anesthesia. Adult mongrel dogs were 
anesthetized with intramuscular ketamine (10 mg/kg) and 
intravenous odium thiopental (15 mg/kg). After oral 
endotracheal intubation, the lungs were ventilated me- 
chanically with a Harvard pump (Harvard Apparatus, 
Dover, Mass.) at a tidal volume of 20 ml/kg and a 
frequency of 20 breaths/min. Anesthesia was maintained 
with 50% oxygen, 50% nitrous oxide, and 1% halothane. 
Groups and preservation of grafts. Six to 10 rings of 
trachea were removed and simply immersed in TC solu- 
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tion containing Dulbecco's modified Eagle medium, 10% 
dimethyl sulfoxide (DMSO), 20% fetal calf serum, and 0.1 
mol/L trehalose or Euro-Collins olution. 
Group A. In the cryopreservation group (group A, n = 
12), the harvested tracheas were cryopreserved in TC 
solution and stored in a deep freezer at -85 ° C for 285 _+ 
28 days. 
Group B. In the control group (group B, n = 6), the 
harvested grafts were preserved in Euro-Collins solution 
at 10 ° C for 16 to 17 hours. 
Allotransplantation of trachea. In group A, five rings 
of the mediastinal tracheas were resected and the cryo- 
preserved tracheas were allotransplanted. Before trans- 
plantation the graft was thawed at 37 ° C in an incubator 
and rinsed with physiologic saline solution 10 times. In 
group B, the same procedure was done as in group A after 
the determined preservation time. Tracheal transplanta- 
tion was done by the technique described previously. 1 
Briefly, five rings of mediastinal trachea were removed 
after the preparation of an omental pedicle graft, and a 
tracheal allograft was attached with 4-0 Prolene polypro- 
pylene (Ethicon Inc., Somerville, N. J.) continuous u- 
tures. The anastomotic site and graft were covered with 
the omental pedicle graft. Intramuscular dministration f 
cefazolin sodium (1 gm) was continued aily for 1 week 
after transplantation. 
Follow-up bronchoscopic and histologic examinations. 
In both groups, the graft was examined by bronchoscopy 1, 
2, 3, and 4 weeks after operation. Thereafter, broncho- 
scopic examination was conducted every month. Before 
transplantation, one ring of the preserved trachea was 
resected and fixed in 10% formalin. When the experimen- 
tal animals either died or were killed, transplanted grafts 
were removed and fixed in 10% formalin. Thus preserved 
grafts were examined histopathologically both before and 
after transplantation. 
The experimental dogs were treated with humane care 
according to the guidelines outlined in "The Guide for the 
Care and Use of Laboratory Animals" prepared by the 
Institute of Laboratory Animal Resources and published 
by the National Institutes of Health (NIH Publication No. 
86-23). 
Results 
Surviving animals (Table I). In the eryopreserva- 
tion group, all animals (n = 12) survived for more 
than 2 months, except one animal killed for patho- 
logic examination 7 days after the operation. In the 
control group, most animals died within 1 month 
mainly because of tracheal stenosis. 
Macroscopic and gross findings. In the cryo- 
preservation group, grafts were incorporated in all 
cases. Stenosis or tracheomalacia was not observed 
in any case (Fig. 1). In the control group, severe 
stenosis was observed in most cases (Fig. 2). 
Histologic evaluation. After cryopreservation, 
the epithelium of the graft was depleted in all cases 
(Fig. 3, A). At 251 days after transplantation, the 
graft was covered with normal epithelium, and the 
Table I. Results of current study 
Survival Causes 
Groups (animal No.) (days) Status of grafts of death 
Cryopreservation group 
cr-1 64 Incorporated Killed 
cr-2 293 Incorporated Killed 
cr-3 251 Incorporated Killed 
cr-4 259 Incorporated Killed 
cr-5 238 Incorporated Killed 
cr-6 231 Incorporated Killed 
cr-7 231 Incorporated Killed 
cr-8 231 Incorporated Killed 
cr-9 215 Incorporated Killed 
cr-10 7 Incorporated Killed 
cr-l l 157 Incorporated Alive 
cr-12 150 Incorporated Alive 
Control group 
c-1 14 Severe stenosis Killed 
c-2 37 Severe stenosis Killed 
c-3 15 Severe stenosis Killed 
c-4 14 Severe stenosis Killed 
c-5 15 Severe stenosis Killed 
c-6 7 Edematous Killed 
viability of the tracheal cartilages was maintained 
(Fig. 3, B). 
Discussion 
Most candidates for tracheal transplantation have 
malignant diseases, and immunosuppressants can- 
not be given after the operation. To solve this basic 
problem, we developed a new procedure for tra- 
cheocarinal reconstruction in which we used the 
bifurcation of the right upper bronchus (as an 
autograft) to form a new carina. 7 However, the 
results were not fully satisfactory and indications for 
this method will be limited. We next developed a
high-dose irradiation method for tracheal transplan- 
tation. 1 We found that 1000 Gy of gamma-ray 
irradiation prevented rejection of canine tracheal 
allografts. In addition, to solve the donor shortage 
problem, we developed a safe and reliable long-term 
preservation method for tracheas. 2 With use of this 
method, we achieved consistent 1-month tracheal 
cryopreservation. Our next step was to try immuno- 
suppressant-free tracheal allotransplantation after 1 
month of cryopreservation as a preliminary experi- 
ment as mentioned in the former study. 1 In this 
experiment, however, most grafts lost their viability 
presumably because of severe damage derived from 
the combination of irradiation and freezing (unpub- 
lished data) although graft viability had been pre- 
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Fig. 1. Bronchoscopic (A) and macroscopic (B) findings 
293 days after transplantation in cryopreservation group. 
There is no stenosis at anastomotic site or in graft. There 
is no evidence of atrophy in graft. 
Fig. 2. Bronchoscopic (A) and macroscopic (B) find- 
ings 21 days after transplantation in control group. 
Marked stenosis was observed at anastomotic site and 
in graft. 
served in the previous tudies. 1'2 Therefore we gave 
up this approach. 
There have been many reports that the allogenic- 
ity of preserved allografts can be decreased by 
freezing.3-s, 6 Lupinetti and associates s reported that 
cryopreservation denuded heart valves of endothe- 
lium and thus might decrease the allogenicity of the 
graft. We have already reported that the epithelium 
of the trachea plays an important role in graft 
rejection after t ansplantation. 1 Thus we hypothe- 
sized that if after cryopreservation either the struc- 
ture or the function of the tracheal epithelium is 
depleted, immunosuppressant-free tracheal allo- 
transplantation after long-term cryopreservation 
might be possible, as it is after high-dose irradiation 
of the grafts. In fact, after 9 months of cryopreser- 
vation in TC solution, the epithelium of the trachea 
was depleted, and these grafts survived more than 2 
months with preservation of graft viability. Probably 
the grafts that had lost epithelium after cryopreser- 
vation also lost allogenicity and became incorpo- 
rated into the recipient's trachea. In this experi- 
ment, depletion of the epithelium ust have played 
the most important role in the success of tracheal 
transplantation without immunosuppressants. It has 
been reported that thecartilage of the trachea has 
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Fig. 3. A, Histologic findings of tracheal graft cryopreserved for9 months. Epithelium has been depleted. 
However, viability of tracheal cartilage ismaintained (original magnification ×40). B, Histologic finding of 
transplanted graft from animal killed 251 days after operation. Normal epithelium covers urface of graft, 
and viability of tracheal cartilages is maintained (original magnification )<40). 
low immunogenicity 9 and can remain viable after 
cryopreservation.2,10 In this study, after cryopreserva- 
tion of trachea in TC solution, depletion of the epithe- 
lium (modulation of allogenicity) and preservation of
the cartilage (preservation of the architecture) were 
both achieved, and immunosuppressant-free allotrans- 
plantation of the trachea was successful. 
Trehalose is a nonreducing disaccharide that pro- 
tects the cell membrane from various stresses. 11 We 
recently developed new solutions for lung preserva- 
tion with satisfactory results, a2, ~3 TC solution con- 
sists of Dulbecco's modified Eagle medium, 10% 
DMSO, 20% fetal calf serum, and 0.1 mol/L treha- 
lose. DMSO is a cryoprotectant that can penetrate 
cell membranes, whereas trehalose i  a cryopro- 
tectant hat cannot penetrate cell membranes. The 
combined use of these different ypes of cryopro- 
tectants has been reported to exhibit a synergistic 
effect in cryopreservation. 14' 15 Therefore we devel- 
oped a solution that contained both DMSO and 
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trehalose and found that 1-month cryopreservation 
of tracheas with this TC solution was consistently 
successful. 2 The current study revealed that 9-month 
cryopreservation is possible with the use of TC 
solution. Although the basic mechanism of the effect 
of TC solution has not been elucidated in our two 
experiments, TC solution enables immunosuppres- 
sant-free tracheal transplantation after long-term 
cryopreservation. The question of how long a tra- 
cheal graft must be cryopreserved for depletion of 
its allogenicity remains to be answered. 
This approach has solved two basic problems of 
tracheal transplantation: modulation of allogenicity 
and reliable long-term preservation. With this sim- 
ple method, we can stockpile tracheal grafts in 
regional transplant centers, replace grafts when 
needed, and offer cryopreserved tracheas as bioma- 
terial when required. In summary, a new solution 
containing DMSO and trehalose can inhibit canine 
tracheal allogenicity and maintain the viability of the 
grafts after long-term cryopreservation. 
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